The Global Sleep Apnea Devices Market was valued at USD 3.64 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.37% between 2024 and 2030, reaching USD 6.19 billion by 2030. This growth is driven by an increasing incidence of chronic conditions such as cardiovascular diseases and cancers, a rising elderly population, and ongoing technological innovations enhancing product design and development. DelveInsight's Sleep Apnea Devices Market Insights report provides the current and forecast market analysis, individual leading Sleep Apnea Devices companies' market shares, challenges, Sleep Apnea Devices market drivers, barriers, and trends, and key Sleep Apnea Devices companies in the market.\n\nKey Takeaways from the Sleep Apnea Devices Market Report: The Sleep Apnea Devices market is projected to grow at a moderate CAGR from 2025 to 2032. As per DelveInsight estimates, North America is anticipated to dominate the global Sleep Apnea Devices market during the forecast period. Notable Sleep Apnea Devices companies such as Zimmer Biomet, Stryker, Medtronic, Orthofix Medical Inc., NuVasive Inc., B. Braun Melsungen AG, XTANT MEDICAL, Globus Medical, ATEC Spine, Inc., Medacta International, Johnson & Johnson Services, Inc., Captiva Spine, Inc., ZAVATION, and several others are currently operating in the Sleep Apnea Devices market.\n\nIn June 2025, Cerapedics received FDA approval for PearlMatrixTM P-15 Peptide Enhanced Bone Graft, recognized as the first and only clinically proven bone growth accelerator for lumbar fusion. In April 2025, a post-market clinical study published in World Neurosurgery confirmed the significant clinical benefits of Neo Medical's Force Control TechnologyTM in thoracolumbar spinal fusion surgeries. In December 2024, Neo Medical SA, a Swiss spine surgery technology company, announced that its entire product portfolio had been certified under the European Union's Medical Device Regulation (MDR) EU 2017/745, affirming compliance with the highest global standards for medical device quality and safety. In November 2023, Orthofix Medical Inc. reported the full U.S. commercial launch of the WaveForm L Lateral Lumbar Interbody System. Specifically designed for lateral lumbar interbody fusion (LLIF) procedures, this system incorporates a 3D-printed porous structure to enhance both strength and stability, fostering an ideal environment for spinal fusion.\n\nSleep Apnea Devices Overview: Sleep apnea devices are medical systems designed to diagnose and treat sleep apnea—a disorder characterized by repeated interruptions in breathing during sleep. The most common form, obstructive sleep apnea (OSA), occurs when the airway collapses or becomes blocked, while central sleep apnea (CSA) results from the brain failing to signal breathing muscles effectively. If left untreated, sleep apnea can lead to serious complications, including hypertension, cardiovascular disease, stroke, and impaired cognitive function.\n\nSleep Apnea Devices Market Insights: North America is projected to account for the largest revenue share of the spinal fusion devices market in 2024. This dominance is driven by the high prevalence of vertebral compression fractures (VCFs) and the growing incidence of chronic pain in the region. The aging population, combined with lifestyle-related risk factors such as obesity and sedentary behavior, further contributes to the rising burden of spinal disorders. These trends are expected to sustain strong demand for spinal fusion devices, as more patients require surgical solutions for spinal stabilization and pain management from 2025 to 2032. Data from the National Institute of Health (2023) identifies VCFs as the most common type of fragility fracture in the U.S., with an estimated 1-1.5 million cases occurring annually. Research indicates that about 25% of women aged 50 and older will experience at least one VCF, while 40-50% of individuals over 80 are likely to have had a VCF—either as a recent injury or detected incidentally during evaluations for other conditions. For these patients, particularly older adults, spinal fusion devices play a critical role in stabilizing affected vertebrae, restoring spinal alignment, alleviating pain, improving mobility, and preventing further vertebral collapse.\n\nSleep Apnea Devices Market Dynamics: The World Health Organization (WHO) (2024) estimates that approximately 15.4 million people worldwide are living with spinal cord injuries, most of which are caused by preventable traumatic events such as falls or acts of violence. According to WHO data (2023), there were around 619 million cases of lower back pain (LBP) globally, with the number projected to increase to 843 million by 2050. Similarly, the European Pain Federation (2023) reported that about 740 million people experience severe pain at some point in their lives, and in roughly 20% of these cases, the pain lasts for more than three months—classifying it as chronic pain. The rising prevalence of spinal cord injuries, ongoing lower back pain, and chronic pain worldwide is significantly driving demand for spinal fusion devices. Spinal fusion is often the surgical treatment of choice to relieve pain and stabilize the vertebrae, while spinal stabilization technologies are essential in cases of spinal cord injury to restore structural integrity, limit nerve damage, and improve quality of life. Furthermore, DelveInsight Business Research LLP (2023) data shows that among the 7MM, the U.S. recorded the highest diagnosed prevalence of degenerative disc disease, with nearly 12.9 million cases in 2023—a figure expected to grow by 2034. When conservative approaches such as physical therapy, medication, or injections are unsuccessful, spinal fusion surgery is recommended to stabilize the spine and reduce pain, further propelling the spinal fusion devices market.\n\nSleep Apnea Devices Market Drivers: Rising instances of spinal disorders, rising trauma and sports-related injuries, increasing cases of chronic pain, and increase in product development activities.\n\nScope of the Sleep Apnea Devices Market Report: Coverage: Global. Study Period: 2022 to 2032. Key Sleep Apnea Devices Companies: Zimmer Biomet, Stryker, Medtronic, Orthofix Medical Inc., NuVasive Inc., B. Braun Melsungen AG, XTANT MEDICAL, Globus Medical, ATEC Spine, Inc., Medacta International, Johnson & Johnson Services, Inc., Captiva Spine, Inc., ZAVATION, and others.

Sleep Apnea Devices Market Poised for Steady Growth, Fueled

The global sleep apnea devices market was valued at USD 3.64 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.37% from 2024 to 2030, reaching USD 6.19 billion by 2030. This growth is driven by increasing incidences of chronic conditions such as cardiovascular diseases and cancers, an aging population, and technological advancements in device design. North America is expected to dominate the market during the forecast period due to high prevalence of vertebral compression fractures and chronic pain. Key companies including Zimmer Biomet, Stryker, Medtronic, Orthofix Medical Inc., NuVasive Inc., B. Braun Melsungen AG, Neo Medical SA, and others are active in the market. Recent developments include Cerapedics receiving FDA approval for PearlMatrixTM P-15 in June 2025, Neo Medical SA achieving full EU MDR certification in December 2024, and Orthofix Medical launching the WaveForm L Lateral Lumbar Interbody System in November 2023.